Pascal Steenvoorde

Isala

Papers

1

Total Citations

55

H-Index

1

About

Pascal Steenvoorde is a leading surgical researcher whose work centers on minimally invasive pancreatic surgery, cost-effectiveness in healthcare, and patient-reported outcomes. His most impactful contribution comes from the LEOPARD trial, a landmark randomized study comparing minimally invasive and open distal pancreatectomy. This work, cited over 55 times, demonstrated that the minimally invasive approach reduces time to functional recovery, while also rigorously analyzing associated costs and quality-of-life metrics—providing crucial evidence for surgical decision-making. Steenvoorde’s research bridges the gap between clinical efficacy and economic viability, helping to shape modern surgical protocols. His focus on patient-centered outcomes ensures that surgical innovation translates into tangible benefits for those undergoing complex procedures. Through high-impact trials like LEOPARD, Steenvoorde has established himself as a key voice in evidence-based surgery, influencing both practice guidelines and future research directions in pancreatic oncology and surgical innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
55
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial)
55 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Isala

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago